Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
DSCSA 2023: Dispensers’ Role and Responsibilities
At HDA’s third Traceability Webinar on September 15, HDA’s Elizabeth Gallenagh, General Counsel and Senior Vice President, Supply Chain Integrity, spoke to Perry Fri, Executive Vice President, Industry Relations, Membership and Education, HDA; and Chief Operating Officer, HDA Research Foundation to dispel myths and offer clarity around the dispenser’s role and legal responsibilities per DSCSA requirements.
HDA Launches New Communications Initiative, “We Are Health Delivered”
HDA launched a new initiative, “We Are Health Delivered,” to underscore the pharmaceutical distribution’s industry’s united commitment to delivering health to communities across America.
Member Spotlight: The Future of Cold Chain Solutions
For HDA service provider member AeroSafe Global, innovation and sustainability go hand in hand. Since 1995, the company has grown from a single laboratory in Rochester, New York, into a global leader on the cutting edge of cold chain technology solutions.
A Conversation About Pharmaceutical Supply Chain Resilience and COVID-19
On October 27, HDA and The Hill brought together policymakers, leaders in the pharmaceutical industry and public health experts to discuss the supply chain’s response during COVID-19. In conversation with Steve Clemons, Editor-in-Chief of The Hill, speakers provided key insights on ensuring the strength and resilience of the pharmaceutical supply chain during this unprecedented crisis. Below are five takeaways from the dialogue.
HDA Survey Results Indicate More Preparation Necessary for Connecting EPCIS-Enabled Systems Before DSCSA Deadline
Data released by the Healthcare Distribution Alliance (HDA) indicate more preparation is needed to ensure all healthcare supply chain partners are ready to meet the requirements of the Drug Supply Chain Security Act (DSCSA). HDA’s latest EPCIS Implementation Benchmarking Survey provides a final report on supply chain partners’ progress toward the November 27, 2023, deadline to connect data systems to exchange serialized transaction data for all pharmaceuticals.